Cargando…
Rational Use of Danofloxacin for Treatment of Mycoplasma gallisepticum in Chickens Based on the Clinical Breakpoint and Lung Microbiota Shift
The study was to explore the rational use of danofloxacin against Mycoplasma gallisepticum (MG) based on its clinical breakpoint (CBP) and the effect on lung microbiota. The CBP was established according to epidemiological cutoff value (ECV/CO(WT)), pharmacokinetic–pharmacodynamic (PK–PD) cutoff val...
Autores principales: | Wang, Shuge, Huang, Anxiong, Gu, Yufeng, Li, Jun, Huang, Lingli, Wang, Xu, Tao, Yanfei, Liu, Zhenli, Wu, Congming, Yuan, Zonghui, Hao, Haihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944443/ https://www.ncbi.nlm.nih.gov/pubmed/35326865 http://dx.doi.org/10.3390/antibiotics11030403 |
Ejemplares similares
-
Prudent Use of Tylosin for Treatment of Mycoplasma gallisepticum Based on Its Clinical Breakpoint and Lung Microbiota Shift
por: Huang, Anxiong, et al.
Publicado: (2021) -
Exploration of Clinical Breakpoint of Danofloxacin for Glaesserella parasuis in Plasma and in PELF
por: Xu, Zihui, et al.
Publicado: (2021) -
The PK–PD Relationship and Resistance Development of Danofloxacin against Mycoplasma gallisepticum in An In Vivo Infection Model
por: Zhang, Nan, et al.
Publicado: (2017) -
Determination of the Mutant Selection Window and Evaluation of the Killing of Mycoplasma gallisepticum by Danofloxacin, Doxycycline, Tilmicosin, Tylvalosin and Valnemulin
por: Zhang, Nan, et al.
Publicado: (2017) -
Relationship between danofloxacin PK/PD parameters and emergence and mechanism of resistance of Mycoplasma gallisepticum in In Vitro model
por: Zhang, Nan, et al.
Publicado: (2018)